FDA looks into cancer concerns related to insulin Lantus

07/2/2009 | Bloomberg

The FDA is examining Sanofi-Aventis' insulin Lantus after reports released last week linked the drug to an increased risk of tumors. The move comes days after diabetes experts urged patients to continue using Lantus despite the possible risk.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ